Evaluation of the Effect of Biomarker Levels Associated with Disease Severity on Mortality in COVID-19 Patients in the Gaziantep Region of Turkey

被引:0
|
作者
Gurbuz, Huseyin [1 ]
Bayrakci, Sinem [2 ]
Bayrakci, Onur [3 ]
Cicek, Hulya [4 ]
机构
[1] Dr Ersin Arslan Training & Res Hosp, Dept Emergency Med, Gaziantep, Turkiye
[2] Dr Ersin Arslan Training & Res Hosp, Dept Intens Care, Gaziantep, Turkiye
[3] Dr Ersin Arslan Training & Res Hosp, Dept Thorac Surg, Gaziantep, Turkiye
[4] Gaziantep Univ, Fac Med, Dept Med Biochem, Gaziantep, Turkiye
关键词
COVID-19; D-Dimer; CK-MB; Ferritin; Cardiac troponin-I; TROPONIN; HYPERTENSION; DEATH;
D O I
10.18016/ksutarimdoga.vi.1189752
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
This study aimed to investigate the effect of clinical and some specific laboratory parameters on the prognosis and mortality of critically ill COVID-19 patients who need to be followed in the intensive care unit (ICU). This is a retrospective cohort study. A total of 180 patients treated in the ICU were included in the study. The data of clinical and levels of D-dimer, cardiac troponin I (cTnI), Ferritin, and CK-MB were researched. The multivariate and univariate logistic regression models were employed to investigate the risk factors affiliated with in-hospital death. There was a significant difference in mortality between women and men (p=0.002). Hypertension was the most common comorbid disease, mortality was detected to be significantly greater in patients over 65 years of age. The serum D-dimer, cTnI, CK-MB, and ferritin levels were found to be higher in patients at risk. In the multivariate logistic regression model, we detected that ferritin above 300 mu g/l (p=0.05) alongside cancer was associated with mortality. This study showed that advanced age is an important risk factor as well as the mortality of patients with cancer -especially those with a ferritin value above 300 mu g/l and patients with a high cTnI value.
引用
收藏
页码:1239 / 1245
页数:7
相关论文
共 50 条
  • [1] Biomarker profiles associated with COVID-19 severity and mortality
    Sanchez-Diez, S.
    Gomez Olles, C.
    De Homdedeu, M.
    Espejo, D.
    Fabregas, C.
    Cruz, M. J.
    Munoz, X.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [2] Biomarker Profiles Associated with COVID-19 Severity and Mortality
    Sanchez-Diez, Silvia
    Gomez-Olles, Carlos
    Cruz, Maria-Jesus
    de Homdedeu, Miquel
    Espejo, David
    Ferrer, Jaume
    Roca, Oriol
    Pacheco, Andres
    Munoz, Xavier
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (03) : 1998 - 2012
  • [3] Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients
    Welder, Daniel
    Jeon-Slaughter, Haekyung
    Ashraf, Bilal
    Choi, Sung-Hee
    Chen, Weina
    Ibrahim, Ibrahim
    Bat, Taha
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (03) : 530 - 536
  • [4] Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality
    von Meijenfeldt, Fien A.
    Havervall, Sebastian
    Adelmeijer, Jelle
    Lundstrom, Annika
    Rudberg, Ann-Sofie
    Magnusson, Maria
    Mackman, Nigel
    Thalin, Charlotte
    Lisman, Ton
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (01) : 132 - 141
  • [5] Thrombocytopenia Associated with Increase in Disease Severity and Mortality in COVID-19 Patients
    Banwait, Ranjit
    Marachi, Aya
    Iyer, Uma G.
    BLOOD, 2020, 136
  • [6] ?' fibrinogen levels as a biomarker of COVID-19 respiratory disease severity
    Kornblith, Lucy Z.
    Sadhanandhan, Bindhya
    Arun, Sreepriya
    Long, Rebecca
    Johnson, Alicia J.
    Noll, Jamie
    Ramchand, C. N.
    Olynyk, John K.
    Farrell, David H.
    BLOOD CELLS MOLECULES AND DISEASES, 2023, 101
  • [7] Evaluation of serum procalcitonin level as a biomarker for disease severity in COVID-19 patients
    Waris, A.
    Din, M.
    Iqbal, N.
    Yar, L.
    Khalid, A.
    Nawaz, M.
    Baset, A.
    Ali, M.
    NEW MICROBES AND NEW INFECTIONS, 2021, 43
  • [8] DIABETES IS ASSOCIATED WITH INCREASED MORTALITY AND DISEASE SEVERITY IN HOSPITALIZED PATIENTS WITH COVID-19
    Tabrizi, Fatemeh Moghaddam
    Rasmi, Yousef
    Hosseinzadeh, Elyas
    Rezaei, Sakineh
    Balvardi, Mohadeseh
    Kouchari, Mohammad Reza
    Ebrahimi, Ghasem
    EXCLI JOURNAL, 2021, 20 : 444 - 453
  • [9] Regarding γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity
    Wang, Sangsang
    Yu, Diao
    Zhang, Junwu
    BLOOD CELLS MOLECULES AND DISEASES, 2024, 105
  • [10] Regarding γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity
    Kornblith, Lucy Z.
    Sadhanandhan, Bindhya
    Arun, Sreepriya
    Long, Rebecca
    Johnson, Alicia J.
    Noll, Jamie
    Ramchand, C. N.
    Olynyk, John K.
    Farrell, David H.
    BLOOD CELLS MOLECULES AND DISEASES, 2024, 105